4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-25-063848
Options or other derivatives
- Chief Operating Officer acquired 350,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yonehiro Grant Chief Operating Officer | 2025-05-01 | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…